论文信息 - No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group - 字舞流文

No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group

D. Niederwieser | C. Junghanss | M. Cross | R. Hehlmann | H. Al-Ali | R. Krahl | M. Assmann | T. Lange | M. Pfirrmann | M. Deininger | C. Niederwieser | C. Spohn | V. Lakner | U. von Gruenhagen | K. Jentsch-Ullrich | Arthur Gil | Christian Niederwieser